Epidemiology: Parkinson's DiseaseDatamonitor
January 10, 2011
26 Pages - SKU: DFMN6070355
More Parkinson's Disease reports by Datamonitor
Market and Product Forecasts: Top 10 Neurology Brands 2011–21 by Datamonitor
The diverse field of neurology hosts numerous disorders with substantial unmet clinical need, creating a complex but lucrative market. Considerable rewards are available for the ...
R&D Trends: Parkinson's Disease – Pipeline swells but a paradigm shift is unlikely in the mid-term by Datamonitor
IntroductionSince early 2011, R&D efforts in Parkinson’s disease have been met with mixed success. In Q1 2012, the US FDA re-approved UCB’s Neupro (rotigotine patch), ...
Epidemiology: Parkinson’s Disease – Aging population drives up prevalence by Datamonitor
IntroductionIn this report, Datamonitor has estimated that there were a total of 2.3 million cases of Parkinson’s disease in 2011 in the seven major markets, ...
Pipeline and Commercial Insight: Parkinson's Disease - Reformulations sustain market growth in the absence of therapeutic breakthroughs by DatamonitorSee all reports like this >>
IntroductionIn 2010, the Parkinson’s disease market is estimated to generate $2.2bn across the seven major markets. As the market approaches maturity, Datamonitor forecasts growth to ...
We can help you find what you need. Call us or write us:
Need help in your search?
Parkinson's Disease Reports
- Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff
- Parkinson's Disease – Pipeline Review, H1 2013
- Parkinson's Disease Global Clinical Trials Review, H2, 2012
- Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
- Market and Product Forecasts: Top 10 Neurology Brands 2011–21